Search research articles
Contact Us
Filters
Showing results (21-30 of 24) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 24 results.
World Neurosurgery: X
|
April 10, 2024
Why are clinical trials of deep brain stimulation terminated? An analysis of clinicaltrials.gov
Akash Mishra, Sabrina L Begley, Harshal A Shah, et al.
Neuroimage. Clinical
|
December 23, 2015
Neural correlates of abnormal sensory discrimination in laryngeal dystonia
Pichet Termsarasab, Ritesh A Ramdhani, Giovanni Battistella, et al.
Journal of Clinical Lipidology
|
July 19, 2018
Diagnosis, treatment, and clinical outcomes in 43 cases with cerebrotendinous xanthomatosis
P Barton Duell, Gerald Salen, Florian S Eichler, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
April 29, 2025
Efficacy, safety, and tolerability of chenodeoxycholic acid (CDCA) in adult patients with cerebrotendinous xanthomatosis (RESTORE): A randomized withdrawal, double-blind, placebo-controlled, crossover phase-3 study
Yaz Y Kisanuki, Paulo R Nobrega, Ryan Himes, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 24) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 24 results.
World Neurosurgery: X
|
April 10, 2024
Why are clinical trials of deep brain stimulation terminated? An analysis of clinicaltrials.gov
Akash Mishra, Sabrina L Begley, Harshal A Shah, et al.
Neuroimage. Clinical
|
December 23, 2015
Neural correlates of abnormal sensory discrimination in laryngeal dystonia
Pichet Termsarasab, Ritesh A Ramdhani, Giovanni Battistella, et al.
Journal of Clinical Lipidology
|
July 19, 2018
Diagnosis, treatment, and clinical outcomes in 43 cases with cerebrotendinous xanthomatosis
P Barton Duell, Gerald Salen, Florian S Eichler, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
April 29, 2025
Efficacy, safety, and tolerability of chenodeoxycholic acid (CDCA) in adult patients with cerebrotendinous xanthomatosis (RESTORE): A randomized withdrawal, double-blind, placebo-controlled, crossover phase-3 study
Yaz Y Kisanuki, Paulo R Nobrega, Ryan Himes, et al.
Page
of 3